Traditional heart failure drug use in cardiac amyloid patients: insights from an international survey

Back

HFA Premium Access

Traditional heart failure drug use in cardiac amyloid patients: insights from an international survey

Session: Chronic heart failure - pathophysiology and mechanisms 2

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Professor N. Mewton (Lyon, FR)

Event: Heart Failure 2024

Congress Presentation

About the speaker

Professor Nathan Mewton

Civils Hospices of Lyon, Lyon (France)

8 presentations

0 follower

6 more presentations in this session

Echocardiographic characteristics of patients with CpcPH, and IpcPH in HFpEF, insight of PHHF study

Speaker: Doctor E. Berthelot (Le Kremlin-Bicetre, FR)

Rationale and design of the PACIFIC-PRESERVED (PhenomApping, ClassIFication, and Innovation for Cardiac dysfunction in patients with heart failure and PRESERVED left ventricular EF) study

Speaker: Professor J. Hulot (Paris, FR)

Effects of SGLT2i on CGA and biomarkers of oxidative stress and platelet activation in elderly diabetic patients with HFpEF.

Speaker: Associate Professor A. Sciacqua (Catanzaro, IT) Doctor G. Armentaro (Catanzaro, IT)

Cardiac amyloidosis awareness comparison between HF-cardiologists, non-HF-cardiologists and other specialties around the world: insights from international survey

Speaker: Miss F. Guidetti (Stockholm, SE)

Echocardiographic iron responders - assessing which HFrEF patients with iron deficiency benefit the most from iron therapy

Speaker: Doctor C. Bakogiannis (Thessaloniki, GR)

Access the full session

Chronic heart failure - pathophysiology and mechanisms 2

Speakers: Professor N. Mewton, Doctor E. Berthelot, Professor J. Hulot, Associate Professor A. Sciacqua, Doctor G. Armentaro...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources